Literature DB >> 21832040

Regulation of RE1 protein silencing transcription factor (REST) expression by HIP1 protein interactor (HIPPI).

Moumita Datta1, Nitai P Bhattacharyya.   

Abstract

Earlier we have shown that the proapoptotic protein HIPPI (huntingtin interacting protein 1 (HIP1) protein interactor) along with its molecular partner HIP1 could regulate transcription of the caspase-1 gene. Here we report that RE1-silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) is a new transcriptional target of HIPPI. HIPPI could bind to the promoter of REST and increased its expression in neuronal as well as non-neuronal cells. Such activation of REST down-regulated expression of REST target genes, such as brain-derived neurotrophic factor (BDNF) or proenkephalin (PENK). The ability of HIPPI to activate REST gene transcription was dependent on HIP1, the nuclear transporter of HIPPI. Using a Huntington disease cell model, we have demonstrated that feeble interaction of HIP1 with mutant huntingtin protein resulted in increased nuclear accumulation of HIPPI and HIP1, leading to higher occupancy of HIPPI at the REST promoter, triggering its transcriptional activation and consequent repression of REST target genes. This novel transcription regulatory mechanism of REST by HIPPI may contribute to the deregulation of transcription observed in the cell model of Huntington disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832040      PMCID: PMC3190832          DOI: 10.1074/jbc.M111.265173

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Loss of normal huntingtin function: new developments in Huntington's disease research.

Authors:  E Cattaneo; D Rigamonti; D Goffredo; C Zuccato; F Squitieri; S Sipione
Journal:  Trends Neurosci       Date:  2001-03       Impact factor: 13.837

2.  Corepressor-dependent silencing of chromosomal regions encoding neuronal genes.

Authors:  Victoria V Lunyak; Robert Burgess; Gratien G Prefontaine; Charles Nelson; Sing-Hoi Sze; Josh Chenoweth; Phillip Schwartz; Pavel A Pevzner; Christopher Glass; Gail Mandel; Michael G Rosenfeld
Journal:  Science       Date:  2002-10-24       Impact factor: 47.728

3.  Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi.

Authors:  François G Gervais; Roshni Singaraja; Steven Xanthoudakis; Claire-Anne Gutekunst; Blair R Leavitt; Martina Metzler; Abigail S Hackam; John Tam; John P Vaillancourt; Vicky Houtzager; Dita M Rasper; Sophie Roy; Michael R Hayden; Donald W Nicholson
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

Review 4.  Lessons from animal models of Huntington's disease.

Authors:  David C Rubinsztein
Journal:  Trends Genet       Date:  2002-04       Impact factor: 11.639

Review 5.  Apoptosis in Huntington's disease.

Authors:  Miriam A Hickey; Marie Françoise Chesselet
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-04       Impact factor: 5.067

6.  Wild-type huntingtin protects from apoptosis upstream of caspase-3.

Authors:  D Rigamonti; J H Bauer; C De-Fraja; L Conti; S Sipione; C Sciorati; E Clementi; A Hackam; M R Hayden; Y Li; J K Cooper; C A Ross; S Govoni; C Vincenz; E Cattaneo
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

7.  Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing.

Authors:  D Rigamonti; S Sipione; D Goffredo; C Zuccato; E Fossale; E Cattaneo
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

8.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

9.  Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells.

Authors:  F Trettel; D Rigamonti; P Hilditch-Maguire; V C Wheeler; A H Sharp; F Persichetti; E Cattaneo; M E MacDonald
Journal:  Hum Mol Genet       Date:  2000-11-22       Impact factor: 6.150

10.  Transcriptional activation of REST by Sp1 in Huntington's disease models.

Authors:  Myriam Ravache; Chantal Weber; Karine Mérienne; Yvon Trottier
Journal:  PLoS One       Date:  2010-12-14       Impact factor: 3.240

View more
  10 in total

Review 1.  Mechanism(s) of alteration of micro RNA expressions in Huntington's disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease.

Authors:  Mithun Sinha; Saikat Mukhopadhyay; Nitai P Bhattacharyya
Journal:  Neuromolecular Med       Date:  2012-05-13       Impact factor: 3.843

2.  Genome wide gene expression regulation by HIP1 Protein Interactor, HIPPI: prediction and validation.

Authors:  Moumita Datta; Ananyo Choudhury; Ansuman Lahiri; Nitai P Bhattacharyya
Journal:  BMC Genomics       Date:  2011-09-26       Impact factor: 3.969

Review 3.  The Transcription Repressor REST in Adult Neurons: Physiology, Pathology, and Diseases

Authors:  Pietro Baldelli; Jacopo Meldolesi
Journal:  eNeuro       Date:  2015-07-10

4.  Grb2 is regulated by foxd3 and has roles in preventing accumulation and aggregation of mutant huntingtin.

Authors:  Shounak Baksi; Nihar R Jana; Nitai Pada Bhattacharyya; Debashis Mukhopadhyay
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

5.  Mutant Huntingtin Protein Interaction Map Implicates Dysregulation of Multiple Cellular Pathways in Neurodegeneration of Huntington's Disease.

Authors:  Sonia Podvin; Sara Brin Rosenthal; William Poon; Enlin Wei; Kathleen M Fisch; Vivian Hook
Journal:  J Huntingtons Dis       Date:  2022

6.  Silencing HIPPI Suppresses Tumor Progression in Non-Small-Cell Lung Cancer by Inhibiting DNA Replication.

Authors:  Guanghui Xie; Yongwen Li; Yongjun Jiang; Xian Ye; Jianfeng Tang; Jun Chen
Journal:  Onco Targets Ther       Date:  2021-05-27       Impact factor: 4.147

7.  Transcription regulation of HYPK by Heat Shock Factor 1.

Authors:  Srijit Das; Nitai Pada Bhattacharyya
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

8.  FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoter.

Authors:  Kai Qian; Jinqian Zhang; Jingbo Lu; Wenjun Liu; Xingxing Yao; Qing Chen; Shun Lu; Guoan Xiang; Hao Liu
Journal:  Oncol Rep       Date:  2015-12-10       Impact factor: 3.906

9.  Differential alterations of positive and negative regulators of beta catenin enhance endogenous expression and activity of beta catenin in A549 non small cell lung cancer (NSCLC) cells.

Authors:  Supratim Ghatak; Sanghamitra Raha
Journal:  Genes Dis       Date:  2016-11-04

10.  REST overexpression in mice causes deficits in spontaneous locomotion.

Authors:  Li Lu; Anantha Marisetty; Bin Liu; Mohamed Mostafa Kamal; Joy Gumin; Bethany Veo; YouQing Cai; Dina Hamada Kassem; Connie Weng; Mark E Maynard; Kimberly N Hood; Gregory N Fuller; Zhizhong Z Pan; Matthew D Cykowski; Pramod K Dash; Sadhan Majumder
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.